1. Home
  2. EXG vs ICUI Comparison

EXG vs ICUI Comparison

Compare EXG & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXG
  • ICUI
  • Stock Information
  • Founded
  • EXG 2007
  • ICUI 1984
  • Country
  • EXG United States
  • ICUI United States
  • Employees
  • EXG N/A
  • ICUI N/A
  • Industry
  • EXG Finance Companies
  • ICUI Medical/Dental Instruments
  • Sector
  • EXG Finance
  • ICUI Health Care
  • Exchange
  • EXG Nasdaq
  • ICUI Nasdaq
  • Market Cap
  • EXG 2.8B
  • ICUI 3.2B
  • IPO Year
  • EXG N/A
  • ICUI 1992
  • Fundamental
  • Price
  • EXG $9.07
  • ICUI $136.29
  • Analyst Decision
  • EXG
  • ICUI Buy
  • Analyst Count
  • EXG 0
  • ICUI 6
  • Target Price
  • EXG N/A
  • ICUI $183.60
  • AVG Volume (30 Days)
  • EXG 533.2K
  • ICUI 297.6K
  • Earning Date
  • EXG 01-01-0001
  • ICUI 11-06-2025
  • Dividend Yield
  • EXG 8.27%
  • ICUI N/A
  • EPS Growth
  • EXG N/A
  • ICUI N/A
  • EPS
  • EXG N/A
  • ICUI N/A
  • Revenue
  • EXG N/A
  • ICUI $2,320,363,000.00
  • Revenue This Year
  • EXG N/A
  • ICUI N/A
  • Revenue Next Year
  • EXG N/A
  • ICUI N/A
  • P/E Ratio
  • EXG N/A
  • ICUI N/A
  • Revenue Growth
  • EXG N/A
  • ICUI N/A
  • 52 Week Low
  • EXG $6.78
  • ICUI $107.00
  • 52 Week High
  • EXG $8.15
  • ICUI $175.51
  • Technical
  • Relative Strength Index (RSI)
  • EXG 43.25
  • ICUI 62.24
  • Support Level
  • EXG $9.05
  • ICUI $116.21
  • Resistance Level
  • EXG $9.38
  • ICUI $144.85
  • Average True Range (ATR)
  • EXG 0.10
  • ICUI 5.67
  • MACD
  • EXG -0.01
  • ICUI 1.59
  • Stochastic Oscillator
  • EXG 39.42
  • ICUI 60.72

About EXG Eaton Vance Tax-Managed Global Diversified Equity Income Fund of Beneficial Interest

Eaton Vance Tax-Mgd Glbl Div Eq Inc is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary focus of the fund is capital appreciation. It invests in a diversified portfolio of domestic and foreign common stocks, emphasizing dividend-paying stocks. It writes call options on one or more U.S. and foreign indices for a portion of the value of its common stock portfolio to generate current cash flow from the options premium received. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, consumable fuels, and other sectors.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: